Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium
Presentation addressed potential applications in prolonged field care and military wound management settings WINNIPEG, Manitoba, Aug.
25, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “K
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.